Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01133639
Other study ID # 2010P000047
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date May 2010
Est. completion date February 2012

Study information

Verified date August 2019
Source Beth Israel Deaconess Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This will be a randomized double-blind placebo-controlled clinical trial that will accept all eligible consecutive patients undergoing elective Kalish bunionectomies. Patients will be randomized into either receiving ketorolac (30 mg IV dose intra-operatively followed by 10 mg orally every 8 hours for five days) plus standard of care or placebo plus standard of care. The purpose of this study is to evaluate the effects of ketorolac plus standard of care on post-operative pain control and radiographic osseous healing. Patients will be assessed for pain via a validated pain questionnaire and for delayed unions via a radiographic scoring system shown to have both high inter- and intra-observer reliability by a blinded board certified radiologist. Additional outcomes of bunionectomy procedures will also be evaluated including adverse events and time to regular shoe gear and activities.


Recruitment information / eligibility

Status Terminated
Enrollment 18
Est. completion date February 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Hallux abductus with bunion deformity

- Adult patients as defined by >=18 years old and <= 65 years old

- Subject has adequate perfusion, verified by the surgeon, which is defined by palpable pedal pulses

- Subject has voluntarily signed and dated an informed consent form, approved by IRB, and provided HIPAA (or other applicable privacy regulation) authorization prior to any participation in the study

- Subject agrees not to take any new medications, dietary supplements, or alternative therapies during the study period (approximately 12 weeks)

- Subject is interested in participating in the study and willing to comply with the study protocol

- Patient has pain related to a bunion deformity but pain-free metatarsalphalangeal joint (MTPJ) range of motion that is not functionally adapted

- Adequate bone density to withstand a Kalish bunionectomy procedure

- No frontal plane hallux deformity

- Minimal abnormality of the PASA

- Normal to minimally malaligned sagittal plane position of the first metatarsal

- Failure of conservative treatment

- General Pre-operative Radiographic Angle Criteria† - 10-15 degree IMA in rectus feet* - 20-25 degree TAA in adducted feet* - 15-20 degree IMA in rectus feet if wide metatarsal head width - 25-30 degree TAA in adducted feet if wide metatarsal head width IMA=intermetatarsal angle; TAA=total adductus angle *If the pre-operative IMA is <15 degree, only the IMA will be used pre-operatively. For IMA >=15, the total adductus angle will be used †These are general guidelines and the width of the metatarsal as well as the presence of positional, structural, or combined first ray deformity may also influence procedure selection.

Exclusion Criteria:

- a history of an allergic-type reaction in response to exposure to aspirin, phenylacetic acid derivatives, or other NSAIDs

- hypersensitivity to ketorolac tromethamine, or to any product component

- any known bleeding risk or bleeding disorder, suspected or confirmed

- history of or active cerebrovascular bleeding, suspected or confirmed

- concomitant aspirin or NSAID use where the patient may not be advised to discontinue the medication during the study

- concomitant pentoxifylline use

- concomitant probenecid use

- coronary artery bypass graft (CABG) surgery within one year of the procedure

- any history of gastrointestinal bleeding/perforation, gastrointestinal ulcer, severe peptic ulcer disease, or severe inflammatory bowel disease

- hemorrhagic diathesis, suspected or confirmed

- incomplete intraoperative hemostasis

- pre-operative serum creatinine > 1.5 ml/dL or blood urea nitrogen level > 22 mg/dL

- any history of renal impairment or risk of renal failure due to volume depletion

- Patients with a known allergy, contraindication and/or intolerance for oxycodone 5mg - acetaminophen 325 mg will be excluded from the study.

- Patients with a known allergy, contraindication, and/or intolerance for the local anesthetic (bupivicaine) or any of the standardized intra-operative opioids and anti-emetics administered by the anesthesiologist

- Patients with a history of fibromyalgia or opioid abuse

- History of chronic regional pain syndrome or diagnosis of any chronic pain syndrome, patients requiring routine methadone or other opioids

- Neuropathy or radiculopathy

- Subject has alcohol or substance abuse, dementia, brain metastases, or other cognitive disorders that may interfere with pain assessment and the post-operative course outlined by the surgeon

- American Society of Anesthesiologists (ASA) Physical Status class four or higher

- women who are pregnant, planning on becoming pregnant, or breast feeding

- presence of active local or systemic infection

- subject has a myocardial infarction in the last twelve months

• Patients who are not candidates for a Kalish bunionectomy due to the preoperative deformity as well as other study exclusions are:

- Absent pedal pulses or ABI < 0.9 and > 1.2

- Concomitant midfoot and rearfoot procedures

- Moderate to high abnormal PASA angles

- Significant sagittal plane first metatarsal deformity

- Moderate to severe osteoporosis as evaluated by preoperative radiographs and/or bone mineral density tests

- Revision cases

- History of previous infections, radiation treatment, or current infection related to the surgical site

- History of previous trauma of the first metatarsal or first ray

- Subject has known immunosuppression (HIV, recent chemotherapy, organ transplant)

- Patients taking systemic steroid (patients taking less than 5 mg of prednisone, inhaled steroids for asthma or chronic obstructive pulmonary disease, topical or optical steroids will not be excluded)

- Subject has active malignancy, excluding cutaneous malignancies except melanoma Pregnancy Elective bunion surgery will not be performed if the patient is pregnant or planning on becoming pregnant during this study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketorolac
30 mg IV dose intra-operatively followed by 10 mg orally every 8 hours for five days plus standard of care
Placebo
Placebo plus standard of care

Locations

Country Name City State
United States Beth Israel Deaconess Medical Center Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center American College of Foot and Ankle Surgeons

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-Operative Pain 18 subjects were enrolled & completed the study. Pharmacy held the randomization table. PI left institution & was never unblinded (because there were never any AEs). Therefore, do not know which subjects were in the placebo vs ketorolac arms. Study was terminated due to lack of administrative support 2/2012 & all data has been destroyed. Post-Operative Day 2
Primary Osseous Healing Radiographic assessment by a blinded board certified radiologist 3 months
Secondary Post-operative Activity Recovery Functional Recovery Index up to 3 months
Secondary Adverse Events Comparison of adverse events between the two study arms 1 week
Secondary Quantity of Narcotic Medication Comparison of quantity of narcotic medication utilized within the two study arms 1 week
See also
  Status Clinical Trial Phase
Completed NCT01435577 - Intravenous Tapentadol in Post-Bunionectomy Pain Phase 2
Terminated NCT05082012 - Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D) N/A
Terminated NCT03257540 - Early Weight-Bearing After Lapidus Arthrodesis
Completed NCT04518462 - Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries Phase 3
Completed NCT04084262 - Multi-Plane Hallux Valgus Correction With the Phantom® Nail
Active, not recruiting NCT03740282 - Early Weight-Bearing After the Lapiplasty Procedure N/A
Completed NCT01743625 - Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain Phase 3
Completed NCT01484652 - Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension Phase 3
Recruiting NCT05831449 - CPL-01 in the Management of Postoperative Pain After Bunionectomy Phase 3
Completed NCT04826328 - Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy Phase 1
Recruiting NCT05773846 - A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain Phase 3
Completed NCT03653429 - Efficacy of Tranexamic Acid in Foot and Ankle Surgeries Phase 4
Recruiting NCT04751344 - Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery Phase 4
Withdrawn NCT03954639 - Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries Phase 3
Completed NCT04002089 - Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy Phase 1
Terminated NCT02499575 - Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures N/A
Completed NCT00613938 - A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy. Phase 3
Completed NCT03246971 - Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain Phase 2
Completed NCT00890682 - Study of Postoperative Analgesia in Bunionectomy Phase 3
Active, not recruiting NCT05602844 - Clinical Trial on Patient-Specific-Instrumentation Assisted Lapidus Fusion for Hallux Valgus N/A